NDAORALTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
Approved
Jun 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
(CNS) stimulant. The mode of therapeutic action in ADHD is not known.
Pharmacologic Class:
Central Nervous System Stimulant
Clinical Trials (5)
Methylphenidate for Apathy in Veterans With Parkinson's Disease
Started Jan 2024
60 enrolled
Parkinson DiseaseApathy
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Started Oct 2019
430,000 enrolled
Attention Deficit Disorder With Hyperactivity
A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD
Started Sep 2018
0Attention Deficit Hyperactivity Disorder
Concerta (Methylphenidate) -To-Generic Switch Study
Started Sep 2015
1,464 enrolled
Attention Deficit Disorder With Hyperactivity
Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder
Started Jan 2015
60 enrolled
Attention Deficit Hyperactivity Disorder
Loss of Exclusivity
LOE Date
Jan 25, 2038
144 months away
Patent Expiry
Jan 25, 2038